Olema Pharmaceuticals Statistics
Total Valuation
OLMA has a market cap or net worth of $279.16 million. The enterprise value is -$112.40 million.
Important Dates
The next estimated earnings date is Tuesday, August 5, 2025, after market close.
Earnings Date | Aug 5, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
OLMA has 68.42 million shares outstanding. The number of shares has increased by 34.97% in one year.
Current Share Class | 68.42M |
Shares Outstanding | 68.42M |
Shares Change (YoY) | +34.97% |
Shares Change (QoQ) | +29.84% |
Owned by Insiders (%) | 4.58% |
Owned by Institutions (%) | 64.80% |
Float | 43.11M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.73 |
P/TBV Ratio | 0.73 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 15.22, with a Debt / Equity ratio of 0.00.
Current Ratio | 15.22 |
Quick Ratio | 15.14 |
Debt / Equity | 0.00 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -41.59% and return on invested capital (ROIC) is -29.65%.
Return on Equity (ROE) | -41.59% |
Return on Assets (ROA) | -27.44% |
Return on Invested Capital (ROIC) | -29.65% |
Return on Capital Employed (ROCE) | -38.53% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.34M |
Employee Count | 96 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -69.91% in the last 52 weeks. The beta is 2.01, so OLMA's price volatility has been higher than the market average.
Beta (5Y) | 2.01 |
52-Week Price Change | -69.91% |
50-Day Moving Average | 4.49 |
200-Day Moving Average | 7.42 |
Relative Strength Index (RSI) | 39.57 |
Average Volume (20 Days) | 777,608 |
Short Selling Information
The latest short interest is 6.30 million, so 9.21% of the outstanding shares have been sold short.
Short Interest | 6.30M |
Short Previous Month | 5.90M |
Short % of Shares Out | 9.21% |
Short % of Float | 14.61% |
Short Ratio (days to cover) | 7.24 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -147.79M |
Pretax Income | -109.63M |
Net Income | -128.89M |
EBITDA | -147.36M |
EBIT | -147.79M |
Earnings Per Share (EPS) | -$1.95 |
Full Income Statement Balance Sheet
The company has $392.71 million in cash and $1.15 million in debt, giving a net cash position of $391.56 million or $5.72 per share.
Cash & Cash Equivalents | 392.71M |
Total Debt | 1.15M |
Net Cash | 391.56M |
Net Cash Per Share | $5.72 |
Equity (Book Value) | 383.45M |
Book Value Per Share | 5.61 |
Working Capital | 370.60M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$124.83 million and capital expenditures -$6,000, giving a free cash flow of -$124.84 million.
Operating Cash Flow | -124.83M |
Capital Expenditures | -6,000 |
Free Cash Flow | -124.84M |
FCF Per Share | -$1.82 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
OLMA does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -34.97% |
Shareholder Yield | -34.97% |
Earnings Yield | -46.17% |
FCF Yield | -44.72% |
Analyst Forecast
The average price target for OLMA is $24.50, which is 500.49% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $24.50 |
Price Target Difference | 500.49% |
Analyst Consensus | Strong Buy |
Analyst Count | 4 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |